Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03517761 · ClinicalTrials.gov registry record · NA
Use of Bone Marrow Concentrate for Treatment of Alar, Accessory, and Transverse Ligament Injuries
A NA study of Craniocervical Injuries, sponsored by Regenexx.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03517761: Recruiting NA study of Craniocervical Injuries, sponsored by Regenexx.
NCT03517761 is a NA study of Craniocervical Injuries that is actively recruiting participants, run by Regenexx. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03517761, a NA study of Craniocervical Injuries, is actively recruiting participants, sponsored by Regenexx.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effectiveness of using anterior approach through the posterior oropharynx for treating alar and transverse ligament injuries with bone marrow concentrate for patients with craniocervical junction (CCJ) instability.
Primary Outcome
The difference between treatment groups in the within patient mean change from baseline to 6 months in Headache Impact Test scores.
Conditions Studied
Interventions
- BIOLOGICAL Bone Marrow Concentrate treatment
- OTHER Sham Control
Study Locations (1)
Colorado
- Ehren Dodson - Broomfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-03-23 |
| Est. Completion | 2030-12 |
| Phase | NA |
What NCT03517761 shows while recruiting
NCT03517761 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Craniocervical Injuries appearing as the primary indexed condition, and to 2 interventions - of which Bone Marrow Concentrate treatment is the first listed.
NCT03517761 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03517761 about?
NCT03517761 is a clinical study titled "Use of Bone Marrow Concentrate for Treatment of Alar, Accessory, and Transverse Ligament Injuries". The purpose of this study is to evaluate the effectiveness of using anterior approach through the posterior oropharynx for treating alar and transverse ligament injuries with bone marrow concentrate for patients with craniocervical junction (CCJ) instability.
What is the current status of trial NCT03517761?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2018-03-23. Estimated completion is 2030-12.
What conditions does trial NCT03517761 study?
This clinical trial studies the following conditions: Craniocervical Injuries.
What interventions are being tested in trial NCT03517761?
The interventions under investigation include: Bone Marrow Concentrate treatment (BIOLOGICAL), Sham Control (OTHER).
Who is sponsoring clinical trial NCT03517761?
This trial is sponsored by Regenexx, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03517761 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03517761's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI